首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   6548篇
  免费   3493篇
林业   176篇
农学   431篇
  1295篇
综合类   145篇
农作物   93篇
水产渔业   2498篇
畜牧兽医   4146篇
园艺   10篇
植物保护   1247篇
  2021年   127篇
  2020年   464篇
  2019年   1020篇
  2018年   893篇
  2017年   932篇
  2016年   922篇
  2015年   807篇
  2014年   792篇
  2013年   968篇
  2012年   447篇
  2011年   471篇
  2010年   594篇
  2009年   238篇
  2008年   233篇
  2007年   85篇
  2006年   104篇
  2005年   88篇
  2004年   101篇
  2003年   92篇
  2002年   107篇
  2001年   75篇
  2000年   111篇
  1999年   18篇
  1997年   12篇
  1996年   6篇
  1995年   7篇
  1994年   11篇
  1993年   9篇
  1992年   9篇
  1991年   12篇
  1990年   11篇
  1989年   7篇
  1988年   7篇
  1987年   7篇
  1986年   11篇
  1985年   8篇
  1984年   7篇
  1983年   13篇
  1979年   9篇
  1978年   17篇
  1977年   10篇
  1975年   12篇
  1974年   11篇
  1973年   10篇
  1972年   12篇
  1971年   9篇
  1970年   10篇
  1969年   6篇
  1968年   8篇
  1961年   5篇
排序方式: 共有10000条查询结果,搜索用时 808 毫秒
181.
Canine inflammatory mammary cancer (IMC) has been proposed as a model for the study of human inflammatory breast cancer (IBC). The aims of this study were to compare the immunohistochemical expression of aromatase (Arom) and several hormone receptors [estrogen receptor α (ERα), estrogen receptor β (ERβ), progesterone receptor (PR) and androgen receptor (AR)], in 21 IMC cases vs 19 non‐IMC; and to study the possible effect of letrozole on canine IMC and human inflammatory breast cancer (IBC) in vitro using IPC‐366 and SUM‐149 cell lines. Significant elevations of the means of Arom Total Score (TS), ERβ TS and PR TS were found in the IMC group (p = 0.025, p = 0.038 and p = 0.037, respectively). Secondary IMC tumours expressed higher levels of Arom than primary IMC (p = 0.029). Non‐IMC PR‐ tumours contained higher levels of Arom than non‐IMC PR+ tumours (p = 0.007). After the addition of letrozole, the number of IMC and IBC cells dropped drastically. The overexpression of Arom found and the results obtained in vitro further support canine IMC as a model for the study of IBC and future approaches to the treatment of dogs with mammary cancer, and especially IMC, using Arom inhibitors.  相似文献   
182.
Plasma concentrations of PAG‐1 are used for pregnancy diagnosis and as a marker of placental/foetal well‐being, while those of PAG‐2 may be an indicator of abortion risk in Neospora caninum‐infected cows. Studies have shown that N. caninum infection modifies PAG‐1 and PAG‐2 patterns in maternal blood plasma. However, no prior work has examined the effects of N. caninum infection on concentrations of PAGs in foetal fluids. In this study, PAG‐1, PAG‐2 and pH levels were determined in the amniotic and allantoic fluids of foetuses collected at 152 days of gestation from control uninfected dams and from dams experimentally infected with N. caninum on Day 110 of gestation. Foetal fluids from infected foetuses had significantly higher PAG‐2 concentrations (p = 0.026) and pH values (p = 0.02) than fluids from non‐infected foetuses. In infected foetuses, significantly higher concentrations of PAG‐1 (p < 0.001) and PAG‐2 (p < 0.001) were detected in fluid samples showing antibodies against N. caninum than those without antibodies. Moreover, pH values were significantly higher (p = 0.011) in foetal fluid samples with antibodies than in samples from non‐infected foetuses. In conclusion, this is the first report on the effect of N. caninum infection on PAG levels in foetal fluids. Our results indicate that following the experimental infection of dams with N. caninum on Day 110 of gestation, foetal fluids collected from the infected foetuses of these dams featured higher PAG‐1 and PAG‐2 levels and pH values than fluids from non‐infected controls, provided that the samples tested showed the presence of antibodies. The clinical implications of these findings are that following infection with N. caninum, most cows will experience some level of placental damage and that this injury correlates with foetal fluid PAG levels and pH.  相似文献   
183.
184.
185.
186.
187.
188.
189.
190.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号